NCI and Bidens celebrate “decades of investment and innovation”

To celebrate the 50th anniversary of the National Cancer Act, President Biden thanked “the boundless ingenuity of the world’s best nurses, doctors and researchers.” Few exemplify this ingenuity better than Beatrice Mintz of Fox Chase, whose obituary appears in this week’s issue. The Cancer History Project commemorates both this anniversary and the legacy of Beatrice Mintz.

Celebration of the 50th anniversary of the national cancer law

Ned Sharpless: “I believe our focus on this important story, especially on how our country’s investment in cancer science has transformed the way we understand and deal with disease, provided inspiration and direction to an era. of turmoil, upheaval and uncertainty.

President Biden: “After decades of investment and innovation, and thanks to the boundless ingenuity of the world’s best nurses, doctors and researchers, today we have a much more sophisticated understanding of how best to fight cancer. Thanks to new treatments and knowledge that could not have been imagined in previous generations, the overall cancer death rate in the United States has declined steadily since the early 1990s, with more dramatic declines over the years. in recent years.

Quote of the week

It was the first successful work of its kind. Very few laboratories at the time were attempting to perform experiments on mammalian embryos. It required new technology. I come from a DIY family – you weren’t buying things you could do – and I loved that I had to sort everything out on my own

Beatrice Mintz

Answering the big questions: the legacy of Beatrice Mintz

Beatrice Mintz, PhD, a member of the AACR Academy and a pioneer in several fields of cancer biology, passed away on January 3, 2022 at the age of 100.

Born January 24, 1921 in New York, New York, Mintz graduated magna cum laude from Hunter College and received a master’s degree in 1944 and a doctorate in 1946 from the University of Iowa. Mintz received a Fulbright Research Fellowship at the Universities of Paris and Strasbourg in 1951.

Big questions. That’s what Beatrice Mintz, PhD, the former Jack Schultz Chair in Fundamental Sciences at Fox Chase Cancer Center, has dedicated her career to addressing. Small questions, in his opinion, are not worth the time or the effort. Because of this philosophy – and by the strength of his personality – Mintz’s opus, according to Jonathan Chernoff, MD, Scientific Director of Fox Chase, contains the platforms for several areas, including developmental genetics, technology. transfer of genes, epigenetics and the tumor microenvironment.

Geneticist Beatrice Mintz, PhD, came to Fox Chase in 1960 with a doctorate in zoology from the University of Iowa, time spent teaching at the University of Chicago, and an interest in posing what she called the “big questions”. In her research, she developed mouse models that allowed scientists to identify links between development and cancer. Her work, for which she has received numerous awards, has also enabled scientists to explore the biology of cancer over the lifespan of an animal. She is widely recognized as a pioneer in the field of developmental genetics and its relationship to cancer biology.

Recent contributions

The Rutgers Cancer Institute of New Jersey, first called “The Cancer Institute of New Jersey”, was born in 1993 as a result of a P20 planning grant that was awarded in 1992. In June 2008, the Rutgers Cancer Institute celebrated its 15th anniversary of caring for the sick.

This column presents the latest articles on the Cancer History Project by our growing list of contributors.

The Cancer History Project is a free, web-based collaborative resource to mark the 50th anniversary of the National Cancer Act and designed to continue in perpetuity. The aim is to put together a solid collection of historical documents and make them accessible free of charge.

Access to the project on the history of cancer is open to the public at You can also follow us on Twitter at @CancerHistProj.

Is your establishment a donor to the cancer history project? Eligible institutions include cancer centers, advocacy groups, professional societies, pharmaceutical companies, and key oncology organizations.

To apply and become a contributor, please contact [email protected].

Comments are closed.